Say Hello to the New Species of Fly Officially Approved to Clean Human Wounds

The FDA just cleared a maggot-based wound treatment from a Singapore startup

FDA clears Medifly Maggots from Cuprina for chronic non-healing wound debridement affecting 1-2% of developed-world patients. Validates biotech solution vs. antimicrobial resistance; Cuprina monopolizes FDA-authorized larvae species, establishing market leadership in precision wound care.